Assessment of response to neoadjuvant chemotherapy in advanced ovarian cancer: does the level of CA125 predict an optimal debulking surgery?

被引：0
|
作者：
Ben Ltaief, Sarra [1 ]
Bouhani, Malek [1 ]
Mbarek, Mohamed Mahdi Ben [1 ]
Sakhri, Saida [1 ]
Bouaziz, Hanen [1 ]
Ben Dhiab, Tarek [1 ]
机构：
[1] Inst Salah Aziez Tunisia, Surg Oncol, Tunis Ville, Tunisia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV226/#752
引用
收藏
页码：A200 / A200
页数：1
相关论文
共 50 条
  • [1] Serum CA125 levels predict outcome of interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Zhang, Dan
    Jiang, Yu-xia
    Luo, Shu-juan
    Zhou, Rong
    Jiang, Qing-xiu
    Linghu, Hua
    CLINICA CHIMICA ACTA, 2018, 484 : 32 - 35
  • [2] CA125 kinetic changes predict optimal cytoreduction in patients received neoadjuvant chemotherapy with advanced ovarian cancer
    Zhou, Ying
    Li, Shengxia
    Zhu, Chenchen
    Zhang, Anna
    Ni, Li
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S89 - S90
  • [3] CA125 as a predictive marker for optimal interval debulking surgery in advanced ovarian cancer.
    Furukawa, N.
    Shigetomi, H.
    Yoshida, S.
    Kawaguchi, R.
    Komeda, S.
    Tanase, Y.
    Yamada, Y.
    Kobayashi, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy
    Pelissier, Aurelie
    Bonneau, Claire
    Chereau, Elisabeth
    Rouge, Thibault de la Motte
    Fourchotte, Virginie
    Dargi, Emile
    Rouzier, Roman
    GYNECOLOGIC ONCOLOGY, 2014, 135 (03) : 542 - 546
  • [5] Serum CA 125 Level after Neoadjuvant Chemotherapy is Predictive of Prognosis and Debulking Surgery Outcomes in Advanced Epithelial Ovarian Cancer
    Matsuhashi, Tomohiko
    Takeshita, Toshiyuki
    Yamamoto, Akihito
    Kawase, Rieko
    Yamada, Takashi
    Kurose, Keisuke
    Doi, Daisuke
    Konnai, Katsuyuki
    Onose, Ryo
    Kato, Hisamori
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2017, 84 (04) : 170 - 176
  • [6] The added value of CA125 normalization before interval debulking surgery to the chemotherapy response score for the prognostication of ovarian cancer patients receiving neoadjuvant chemotherapy for advanced disease
    Liang, Wei-feng
    Wang, Li-juan
    Li, Hui
    Liu, Chang-hao
    Wu, Miao-fang
    Li, Jing
    JOURNAL OF CANCER, 2021, 12 (03): : 946 - 953
  • [7] The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking
    Le, T.
    Hopkins, L.
    Faught, W.
    Fung-Kee-Fung, M.
    GYNECOLOGIC ONCOLOGY, 2007, 105 (03) : 712 - 715
  • [8] Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer
    Vergote, IB
    De Wever, I
    Decloedt, J
    Tjalma, W
    Van Gramberen, M
    van Dam, P
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 31 - 36
  • [9] Limitation of CA125 in predicting complete resection after neoadjuvant chemotherapy in advanced ovarian cancer
    Tse, Ka Yu
    Kwok, Shuk
    Chu, Mandy
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A206 - A206
  • [10] Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
    Kazuto Nakamura
    Yoshikazu Kitahara
    Toshio Nishimura
    Soichi Yamashita
    Keiko Kigure
    Ikuro Ito
    Tatsuya Kanuma
    World Journal of Surgical Oncology, 18
12345